Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Oncolytics Biotech submits Orphan Drug Designation for high grade gliomas in pediatric patients

 

Oncolytics Biotech submits Orphan Drug Designation for high grade gliomas in pediatric patients

2015-02-09 15:30:43| Biotech - Topix.net

Oncolytics Biotech Inc. today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration for REOLYSIN for the treatment of high grade gliomas in pediatric patients. Oncolytics has conducted three previous clinical studies in brain cancers including gliomas, and has found that REOLYSIN can infect a variety of brain tumors when delivered intravenously.

Tags: high drug grade patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 18.05 M&S website and app hit by technical issue 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 18.05 Producers to be paid grid premiums for AngusLink beef scores 18.05 This Week in Agribusiness, May 18, 2024 18.05 This Week in Agribusiness, May 18, 2024 More »